Journal of Infectious Diseases

Papers
(The H4-Index of Journal of Infectious Diseases is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Introducing the New Journal of Infectious Diseases Editorial Board, Part I1058
Introducing the New Journal of Infectious Diseases Editorial Board, Part II294
CCL19 (rs3136658) and CCL21 (rs2812377) Variants Are Associated With Susceptibility and Related Mortality of SARS-CoV-2 Infection147
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019135
Pneumococcal Carriage and Seroepidemiology Studies to Measure Current and Future Pneumococcal Conjugate Vaccine Effectiveness123
Reviewers Vol 1 2023119
CCL17 Influences Borrelia burgdorferi Infection in the Heart113
Emergence of Ceftriaxone-Resistant Neisseria gonorrhoeae Through Horizontal Gene Transfer Among Neisseria Species104
Neither the African-Centric S47 Nor P72 Variant of TP53 Is Associated With Reduced Risk of Febrile Malaria in a Malian Cohort Study97
SARS-CoV-2 Infection Causes Hyperglycemia in Cats86
Emergency Myelopoiesis Distinguishes Multisystem Inflammatory Syndrome in Children From Pediatric Severe Coronavirus Disease 201982
sTREM-1 to Risk-Stratify Patients With Malaria: A Functional Crystal Ball to Improve Outcomes and Save Lives78
Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults74
Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants72
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy68
Influenza Vaccine-Averted Illness in Chile, Guyana, and Paraguay During 2013–2018: A Standardized Approach to Assess the Value of Vaccination65
Systematic Review of Household Transmission of Strep A: A Potential Site for Prevention That Has Eluded Attention65
Antiretroviral Therapy Ameliorates Simian Immunodeficiency Virus–Associated Myocardial Inflammation by Dampening Interferon Signaling and Pathogen Response in the Heart65
Insights From Studies of the Genetics, Pathogenesis, and Immunogenicity of the Varicella Vaccine63
Neutrophil-Associated Proteins as Novel Biomarkers Elevated in the Cerebrospinal Fluid of Patients With Neurosyphilis62
Structured Immune Workup in Healthy Children With a First Episode of Severe Bacterial Infection: A 7-year Single-Center Study62
Integrating Ethics in Public Health Guideline Development: Case Study of Guidelines on Respiratory Isolation for Persons With Tuberculosis in Community Settings60
Vaccine-Boosted CCP Decreases Virus Replication and Hastens Resolution of Infection Despite Transiently Enhancing Disease in SARS-CoV-2–Infected Hamsters56
Unique Profile of Inflammation and Immune Activation in Pregnant People With HIV in the United States55
The Sympathetic Nervous System Is Necessary for Development of CD4+ T-Cell Memory Following Staphylococcus aureus Infection55
T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With D55
Alarming Trends in Dengue Incidence and Mortality in Bangladesh54
An Expression Quantitative Trait Locus of Fc Gamma Receptor Genes Is Associated With Antimalarial IgG Responses and Infection Levels in Burkinabe Families52
Invasive Meningococcal Disease Among People Experiencing Homelessness—United States, 2016–201951
A Call to Action: Current Challenges and Considerations for COVID-19 Vaccination in Immunocompromised Populations49
High Mortality Rates Among Individuals Misdiagnosed With Tuberculosis: A Matched Retrospective Cohort Study of Individuals Diagnosed With Tuberculosis in Brazil48
Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza48
Barriers and Strategies for Hepatitis B and C Elimination in Pakistan47
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial47
Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells47
Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials46
Characterization of Virulence-Associated Traits in Mycoplasma penetrans Strains Acting as Likely Etiological Agents of Idiopathic Nongonococcal Urethritis46
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose46
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine45
Unpredicted Protective Function of Fc-Mediated Inhibitory Antibodies for HIV and SARS-CoV-2 Vaccines45
Revaccination for Hepatitis B in Previous Nonresponders Following Hepatitis C Eradication43
Every Body Has Value: Ending Discriminatory Restrictions on Anatomical Donations43
A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants42
Characterizing the Etiology of Recurrent Tuberculosis Using Whole Genome Sequencing: Alaska, 2008–202042
Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B42
0.10402202606201